Tarbox Family Office’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4
Closed -$1K 1125
2021
Q4
$1K Buy
+4
New +$1.17K ﹤0.01% 1045

Other funds holding PRAX

Tarbox Family Office's PRAX Position: Q1 2022 in Review

Tarbox Family Office sold out of Praxis Precision Medicines (PRAX) in Q1 2022, closing a stake of 4 shares — an estimated $1K sold.

Tarbox Family Office first reported a position in PRAX in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 103 funds tracked by Wall St. Rank hold PRAX as of Q1 2022.

  • Tarbox Family Office reported no remaining Praxis Precision Medicines position as of Q1 2022 after selling out during the quarter.
  • Tarbox Family Office sold 4 Praxis Precision Medicines shares in Q1 2022, an estimated $1K.
  • Tarbox Family Office first reported a position in Praxis Precision Medicines in Q4 2021 and held it in 1 quarter.
  • Tarbox Family Office's Praxis Precision Medicines position peaked at $1K in Q4 2021.
  • 103 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2022.

Based on Tarbox Family Office's 13F filing for Q1 2022, filed 25 Apr 2022.